nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—prostate cancer—urinary bladder cancer	0.432	1	CtDrD
Ethinyl Estradiol—ESR2—urinary bladder cancer	0.169	0.619	CbGaD
Ethinyl Estradiol—ESR1—urinary bladder cancer	0.104	0.381	CbGaD
Ethinyl Estradiol—CYP2B6—Thiotepa—urinary bladder cancer	0.0279	0.14	CbGbCtD
Ethinyl Estradiol—AOX1—Methotrexate—urinary bladder cancer	0.0261	0.131	CbGbCtD
Ethinyl Estradiol—ABCB1—Mitomycin—urinary bladder cancer	0.0189	0.095	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—urinary bladder cancer	0.0155	0.0776	CbGbCtD
Ethinyl Estradiol—ABCC2—Carboplatin—urinary bladder cancer	0.0142	0.0713	CbGbCtD
Ethinyl Estradiol—ABCC2—Cisplatin—urinary bladder cancer	0.0121	0.0609	CbGbCtD
Ethinyl Estradiol—ABCC2—Etoposide—urinary bladder cancer	0.0119	0.0599	CbGbCtD
Ethinyl Estradiol—CYP3A4—Thiotepa—urinary bladder cancer	0.00858	0.0431	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—urinary bladder cancer	0.00813	0.0408	CbGbCtD
Ethinyl Estradiol—ABCC2—Methotrexate—urinary bladder cancer	0.00787	0.0395	CbGbCtD
Ethinyl Estradiol—CYP2B6—Cisplatin—urinary bladder cancer	0.00771	0.0387	CbGbCtD
Ethinyl Estradiol—CYP2C8—Fluorouracil—urinary bladder cancer	0.00688	0.0345	CbGbCtD
Ethinyl Estradiol—CYP2C8—Etoposide—urinary bladder cancer	0.00574	0.0288	CbGbCtD
Ethinyl Estradiol—ABCB1—Gemcitabine—urinary bladder cancer	0.00544	0.0273	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—urinary bladder cancer	0.00517	0.026	CbGbCtD
Ethinyl Estradiol—ABCB1—Cisplatin—urinary bladder cancer	0.00395	0.0199	CbGbCtD
Ethinyl Estradiol—ABCB1—Etoposide—urinary bladder cancer	0.00388	0.0195	CbGbCtD
Ethinyl Estradiol—ABCB1—Doxorubicin—urinary bladder cancer	0.00265	0.0133	CbGbCtD
Ethinyl Estradiol—ABCB1—Methotrexate—urinary bladder cancer	0.00257	0.0129	CbGbCtD
Ethinyl Estradiol—CYP3A4—Etoposide—urinary bladder cancer	0.00233	0.0117	CbGbCtD
Ethinyl Estradiol—CYP3A4—Doxorubicin—urinary bladder cancer	0.00159	0.00797	CbGbCtD
Ethinyl Estradiol—SLC10A1—prostate gland—urinary bladder cancer	0.00105	0.0593	CbGeAlD
Ethinyl Estradiol—SLC10A1—seminal vesicle—urinary bladder cancer	0.000886	0.0502	CbGeAlD
Ethinyl Estradiol—CYP3A4—urine—urinary bladder cancer	0.000745	0.0422	CbGeAlD
Ethinyl Estradiol—SLC10A1—renal system—urinary bladder cancer	0.000714	0.0404	CbGeAlD
Ethinyl Estradiol—ESR2—prostate gland—urinary bladder cancer	0.0007	0.0396	CbGeAlD
Ethinyl Estradiol—SHBG—prostate gland—urinary bladder cancer	0.00068	0.0385	CbGeAlD
Ethinyl Estradiol—AOX1—prostate gland—urinary bladder cancer	0.000674	0.0381	CbGeAlD
Ethinyl Estradiol—SLC10A1—female reproductive system—urinary bladder cancer	0.000572	0.0324	CbGeAlD
Ethinyl Estradiol—AOX1—seminal vesicle—urinary bladder cancer	0.00057	0.0323	CbGeAlD
Ethinyl Estradiol—ABCC2—prostate gland—urinary bladder cancer	0.000527	0.0298	CbGeAlD
Ethinyl Estradiol—ESR2—epithelium—urinary bladder cancer	0.000514	0.0291	CbGeAlD
Ethinyl Estradiol—ESR2—smooth muscle tissue—urinary bladder cancer	0.000496	0.0281	CbGeAlD
Ethinyl Estradiol—ESR1—prostate gland—urinary bladder cancer	0.000479	0.0271	CbGeAlD
Ethinyl Estradiol—ESR2—renal system—urinary bladder cancer	0.000477	0.027	CbGeAlD
Ethinyl Estradiol—AOX1—renal system—urinary bladder cancer	0.000459	0.026	CbGeAlD
Ethinyl Estradiol—AOX1—urethra—urinary bladder cancer	0.000451	0.0255	CbGeAlD
Ethinyl Estradiol—ESR2—female reproductive system—urinary bladder cancer	0.000382	0.0216	CbGeAlD
Ethinyl Estradiol—SHBG—female reproductive system—urinary bladder cancer	0.000371	0.021	CbGeAlD
Ethinyl Estradiol—AOX1—female reproductive system—urinary bladder cancer	0.000368	0.0208	CbGeAlD
Ethinyl Estradiol—ABCC2—renal system—urinary bladder cancer	0.000359	0.0203	CbGeAlD
Ethinyl Estradiol—ESR1—epithelium—urinary bladder cancer	0.000352	0.0199	CbGeAlD
Ethinyl Estradiol—ESR2—vagina—urinary bladder cancer	0.000346	0.0196	CbGeAlD
Ethinyl Estradiol—ESR1—smooth muscle tissue—urinary bladder cancer	0.000339	0.0192	CbGeAlD
Ethinyl Estradiol—SHBG—vagina—urinary bladder cancer	0.000336	0.019	CbGeAlD
Ethinyl Estradiol—AOX1—vagina—urinary bladder cancer	0.000333	0.0188	CbGeAlD
Ethinyl Estradiol—ESR1—renal system—urinary bladder cancer	0.000327	0.0185	CbGeAlD
Ethinyl Estradiol—ABCC2—female reproductive system—urinary bladder cancer	0.000287	0.0163	CbGeAlD
Ethinyl Estradiol—CYP2C8—renal system—urinary bladder cancer	0.000269	0.0152	CbGeAlD
Ethinyl Estradiol—ESR1—female reproductive system—urinary bladder cancer	0.000262	0.0148	CbGeAlD
Ethinyl Estradiol—Estriol—ESR2—urinary bladder cancer	0.000261	0.0986	CrCbGaD
Ethinyl Estradiol—Quinestrol—ESR1—urinary bladder cancer	0.000244	0.0919	CrCbGaD
Ethinyl Estradiol—Estramustine—ESR2—urinary bladder cancer	0.000243	0.0917	CrCbGaD
Ethinyl Estradiol—CYP2B6—renal system—urinary bladder cancer	0.000241	0.0137	CbGeAlD
Ethinyl Estradiol—ESR1—vagina—urinary bladder cancer	0.000237	0.0134	CbGeAlD
Ethinyl Estradiol—ESR2—lymph node—urinary bladder cancer	0.000224	0.0127	CbGeAlD
Ethinyl Estradiol—CYP2C8—female reproductive system—urinary bladder cancer	0.000216	0.0122	CbGeAlD
Ethinyl Estradiol—AOX1—lymph node—urinary bladder cancer	0.000215	0.0122	CbGeAlD
Ethinyl Estradiol—Estropipate—ESR2—urinary bladder cancer	0.0002	0.0754	CrCbGaD
Ethinyl Estradiol—CYP2C8—vagina—urinary bladder cancer	0.000195	0.011	CbGeAlD
Ethinyl Estradiol—CYP2B6—female reproductive system—urinary bladder cancer	0.000193	0.0109	CbGeAlD
Ethinyl Estradiol—ABCB1—prostate gland—urinary bladder cancer	0.000189	0.0107	CbGeAlD
Ethinyl Estradiol—Mestranol—ESR1—urinary bladder cancer	0.000185	0.0696	CrCbGaD
Ethinyl Estradiol—Desogestrel—ESR1—urinary bladder cancer	0.000182	0.0688	CrCbGaD
Ethinyl Estradiol—CYP3A4—renal system—urinary bladder cancer	0.000182	0.0103	CbGeAlD
Ethinyl Estradiol—CYP2B6—vagina—urinary bladder cancer	0.000175	0.0099	CbGeAlD
Ethinyl Estradiol—ABCC2—lymph node—urinary bladder cancer	0.000168	0.00952	CbGeAlD
Ethinyl Estradiol—Estriol—ESR1—urinary bladder cancer	0.000161	0.0607	CrCbGaD
Ethinyl Estradiol—ABCB1—seminal vesicle—urinary bladder cancer	0.00016	0.00906	CbGeAlD
Ethinyl Estradiol—ESR1—lymph node—urinary bladder cancer	0.000153	0.00866	CbGeAlD
Ethinyl Estradiol—Estramustine—ESR1—urinary bladder cancer	0.00015	0.0565	CrCbGaD
Ethinyl Estradiol—Etonogestrel—ESR1—urinary bladder cancer	0.000148	0.0557	CrCbGaD
Ethinyl Estradiol—CYP3A4—female reproductive system—urinary bladder cancer	0.000146	0.00826	CbGeAlD
Ethinyl Estradiol—ABCB1—epithelium—urinary bladder cancer	0.000139	0.00788	CbGeAlD
Ethinyl Estradiol—ABCB1—renal system—urinary bladder cancer	0.000129	0.0073	CbGeAlD
Ethinyl Estradiol—ABCB1—urethra—urinary bladder cancer	0.000127	0.00718	CbGeAlD
Ethinyl Estradiol—Conjugated Estrogens—ESR2—urinary bladder cancer	0.000125	0.0471	CrCbGaD
Ethinyl Estradiol—Estrone—ESR2—urinary bladder cancer	0.000124	0.0469	CrCbGaD
Ethinyl Estradiol—Estropipate—ESR1—urinary bladder cancer	0.000123	0.0464	CrCbGaD
Ethinyl Estradiol—Levonorgestrel—ESR1—urinary bladder cancer	0.000104	0.0394	CrCbGaD
Ethinyl Estradiol—ABCB1—female reproductive system—urinary bladder cancer	0.000103	0.00585	CbGeAlD
Ethinyl Estradiol—Danazol—ESR1—urinary bladder cancer	9.51e-05	0.0359	CrCbGaD
Ethinyl Estradiol—Estradiol—ESR2—urinary bladder cancer	9.43e-05	0.0356	CrCbGaD
Ethinyl Estradiol—ABCB1—vagina—urinary bladder cancer	9.35e-05	0.00529	CbGeAlD
Ethinyl Estradiol—Conjugated Estrogens—ESR1—urinary bladder cancer	7.69e-05	0.029	CrCbGaD
Ethinyl Estradiol—Estrone—ESR1—urinary bladder cancer	7.66e-05	0.0289	CrCbGaD
Ethinyl Estradiol—Increased appetite—Doxorubicin—urinary bladder cancer	6.94e-05	0.00151	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—urinary bladder cancer	6.94e-05	0.00151	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—urinary bladder cancer	6.94e-05	0.00151	CcSEcCtD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—urinary bladder cancer	6.91e-05	0.0015	CcSEcCtD
Ethinyl Estradiol—Urticaria—Thiotepa—urinary bladder cancer	6.84e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Malaise—Etoposide—urinary bladder cancer	6.83e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Methotrexate—urinary bladder cancer	6.81e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Thiotepa—urinary bladder cancer	6.8e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Thiotepa—urinary bladder cancer	6.8e-05	0.00148	CcSEcCtD
Ethinyl Estradiol—Oedema—Cisplatin—urinary bladder cancer	6.75e-05	0.00146	CcSEcCtD
Ethinyl Estradiol—Infection—Cisplatin—urinary bladder cancer	6.7e-05	0.00146	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—urinary bladder cancer	6.68e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—urinary bladder cancer	6.66e-05	0.00145	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Cisplatin—urinary bladder cancer	6.62e-05	0.00144	CcSEcCtD
Ethinyl Estradiol—Cough—Etoposide—urinary bladder cancer	6.61e-05	0.00143	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Cisplatin—urinary bladder cancer	6.55e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—urinary bladder cancer	6.52e-05	0.00142	CcSEcCtD
Ethinyl Estradiol—Affect lability—Doxorubicin—urinary bladder cancer	6.42e-05	0.00139	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—urinary bladder cancer	6.42e-05	0.00139	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	6.4e-05	0.00139	CcSEcCtD
Ethinyl Estradiol—Discomfort—Etoposide—urinary bladder cancer	6.37e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Epirubicin—urinary bladder cancer	6.37e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Thiotepa—urinary bladder cancer	6.34e-05	0.00138	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	6.25e-05	0.00136	CcSEcCtD
Ethinyl Estradiol—Fatigue—Gemcitabine—urinary bladder cancer	6.24e-05	0.00135	CcSEcCtD
Ethinyl Estradiol—Constipation—Gemcitabine—urinary bladder cancer	6.19e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—urinary bladder cancer	6.18e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Asthenia—Thiotepa—urinary bladder cancer	6.17e-05	0.00134	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	6.14e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Infection—Etoposide—urinary bladder cancer	6.14e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Epirubicin—urinary bladder cancer	6.13e-05	0.00133	CcSEcCtD
Ethinyl Estradiol—Dysuria—Methotrexate—urinary bladder cancer	6.09e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—Pruritus—Thiotepa—urinary bladder cancer	6.09e-05	0.00132	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Methotrexate—urinary bladder cancer	6.05e-05	0.00131	CcSEcCtD
Ethinyl Estradiol—ABCB1—lymph node—urinary bladder cancer	6.05e-05	0.00342	CbGeAlD
Ethinyl Estradiol—Skin disorder—Etoposide—urinary bladder cancer	6e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Gemcitabine—urinary bladder cancer	5.96e-05	0.0013	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Doxorubicin—urinary bladder cancer	5.89e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Thiotepa—urinary bladder cancer	5.89e-05	0.00128	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Fluorouracil—urinary bladder cancer	5.86e-05	0.00127	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—urinary bladder cancer	5.86e-05	0.00127	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	5.82e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Estradiol—ESR1—urinary bladder cancer	5.81e-05	0.0219	CrCbGaD
Ethinyl Estradiol—Infestation NOS—Methotrexate—urinary bladder cancer	5.8e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Infestation—Methotrexate—urinary bladder cancer	5.8e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Depression—Methotrexate—urinary bladder cancer	5.79e-05	0.00126	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Gemcitabine—urinary bladder cancer	5.72e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Dysuria—Epirubicin—urinary bladder cancer	5.7e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Dizziness—Thiotepa—urinary bladder cancer	5.69e-05	0.00124	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—urinary bladder cancer	5.67e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—urinary bladder cancer	5.66e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Urticaria—Fluorouracil—urinary bladder cancer	5.65e-05	0.00123	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Epirubicin—urinary bladder cancer	5.63e-05	0.00122	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Fluorouracil—urinary bladder cancer	5.63e-05	0.00122	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Cisplatin—urinary bladder cancer	5.56e-05	0.00121	CcSEcCtD
Ethinyl Estradiol—Weight increased—Epirubicin—urinary bladder cancer	5.54e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Epirubicin—urinary bladder cancer	5.51e-05	0.0012	CcSEcCtD
Ethinyl Estradiol—Vomiting—Thiotepa—urinary bladder cancer	5.47e-05	0.00119	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Epirubicin—urinary bladder cancer	5.43e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Infestation—Epirubicin—urinary bladder cancer	5.43e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Rash—Thiotepa—urinary bladder cancer	5.43e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—urinary bladder cancer	5.42e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Thiotepa—urinary bladder cancer	5.42e-05	0.00118	CcSEcCtD
Ethinyl Estradiol—Headache—Thiotepa—urinary bladder cancer	5.39e-05	0.00117	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	5.34e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Cisplatin—urinary bladder cancer	5.33e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Fatigue—Etoposide—urinary bladder cancer	5.33e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—urinary bladder cancer	5.32e-05	0.00116	CcSEcCtD
Ethinyl Estradiol—Constipation—Etoposide—urinary bladder cancer	5.29e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—urinary bladder cancer	5.28e-05	0.00115	CcSEcCtD
Ethinyl Estradiol—Dysuria—Doxorubicin—urinary bladder cancer	5.27e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Fluorouracil—urinary bladder cancer	5.24e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—urinary bladder cancer	5.24e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Methotrexate—urinary bladder cancer	5.24e-05	0.00114	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Methotrexate—urinary bladder cancer	5.21e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—urinary bladder cancer	5.21e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Asthenia—Gemcitabine—urinary bladder cancer	5.19e-05	0.00113	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Methotrexate—urinary bladder cancer	5.17e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Methotrexate—urinary bladder cancer	5.15e-05	0.00112	CcSEcCtD
Ethinyl Estradiol—Weight increased—Doxorubicin—urinary bladder cancer	5.13e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Pruritus—Gemcitabine—urinary bladder cancer	5.12e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Nausea—Thiotepa—urinary bladder cancer	5.11e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Methotrexate—urinary bladder cancer	5.11e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—urinary bladder cancer	5.1e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—urinary bladder cancer	5.1e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Etoposide—urinary bladder cancer	5.09e-05	0.00111	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Etoposide—urinary bladder cancer	5.05e-05	0.0011	CcSEcCtD
Ethinyl Estradiol—Pruritus—Fluorouracil—urinary bladder cancer	5.03e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—urinary bladder cancer	5.03e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—urinary bladder cancer	5.03e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Methotrexate—urinary bladder cancer	5.02e-05	0.00109	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Cisplatin—urinary bladder cancer	4.97e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Gemcitabine—urinary bladder cancer	4.95e-05	0.00108	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Methotrexate—urinary bladder cancer	4.93e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	4.93e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Urticaria—Etoposide—urinary bladder cancer	4.91e-05	0.00107	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Epirubicin—urinary bladder cancer	4.9e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Epirubicin—urinary bladder cancer	4.89e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Etoposide—urinary bladder cancer	4.89e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Etoposide—urinary bladder cancer	4.89e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—urinary bladder cancer	4.89e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Epirubicin—urinary bladder cancer	4.88e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Methotrexate—urinary bladder cancer	4.87e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Fluorouracil—urinary bladder cancer	4.87e-05	0.00106	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—urinary bladder cancer	4.85e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Asthenia—Cisplatin—urinary bladder cancer	4.84e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—urinary bladder cancer	4.84e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—urinary bladder cancer	4.82e-05	0.00105	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—urinary bladder cancer	4.79e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Epirubicin—urinary bladder cancer	4.78e-05	0.00104	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Methotrexate—urinary bladder cancer	4.73e-05	0.00103	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Doxorubicin—urinary bladder cancer	4.72e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Methotrexate—urinary bladder cancer	4.71e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Dizziness—Fluorouracil—urinary bladder cancer	4.71e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Epirubicin—urinary bladder cancer	4.7e-05	0.00102	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Cisplatin—urinary bladder cancer	4.62e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—urinary bladder cancer	4.61e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Alopecia—Methotrexate—urinary bladder cancer	4.6e-05	0.001	CcSEcCtD
Ethinyl Estradiol—Vomiting—Gemcitabine—urinary bladder cancer	4.6e-05	0.000999	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Methotrexate—urinary bladder cancer	4.57e-05	0.000991	CcSEcCtD
Ethinyl Estradiol—Rash—Gemcitabine—urinary bladder cancer	4.56e-05	0.000991	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Gemcitabine—urinary bladder cancer	4.56e-05	0.00099	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—urinary bladder cancer	4.56e-05	0.000989	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Etoposide—urinary bladder cancer	4.55e-05	0.000989	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Methotrexate—urinary bladder cancer	4.54e-05	0.000985	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—urinary bladder cancer	4.53e-05	0.000985	CcSEcCtD
Ethinyl Estradiol—Headache—Gemcitabine—urinary bladder cancer	4.53e-05	0.000985	CcSEcCtD
Ethinyl Estradiol—Vomiting—Fluorouracil—urinary bladder cancer	4.52e-05	0.000982	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—urinary bladder cancer	4.52e-05	0.000982	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—urinary bladder cancer	4.51e-05	0.00098	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—urinary bladder cancer	4.49e-05	0.000975	CcSEcCtD
Ethinyl Estradiol—Rash—Fluorouracil—urinary bladder cancer	4.49e-05	0.000974	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Fluorouracil—urinary bladder cancer	4.48e-05	0.000973	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—urinary bladder cancer	4.48e-05	0.000972	CcSEcCtD
Ethinyl Estradiol—Headache—Fluorouracil—urinary bladder cancer	4.46e-05	0.000968	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—urinary bladder cancer	4.46e-05	0.000968	CcSEcCtD
Ethinyl Estradiol—Asthenia—Etoposide—urinary bladder cancer	4.43e-05	0.000963	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—urinary bladder cancer	4.43e-05	0.000963	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—urinary bladder cancer	4.42e-05	0.000961	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—urinary bladder cancer	4.42e-05	0.00096	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—urinary bladder cancer	4.4e-05	0.000956	CcSEcCtD
Ethinyl Estradiol—Back pain—Methotrexate—urinary bladder cancer	4.39e-05	0.000953	CcSEcCtD
Ethinyl Estradiol—Pruritus—Etoposide—urinary bladder cancer	4.37e-05	0.000949	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Doxorubicin—urinary bladder cancer	4.35e-05	0.000944	CcSEcCtD
Ethinyl Estradiol—Alopecia—Epirubicin—urinary bladder cancer	4.31e-05	0.000936	CcSEcCtD
Ethinyl Estradiol—Nausea—Gemcitabine—urinary bladder cancer	4.3e-05	0.000933	CcSEcCtD
Ethinyl Estradiol—Vomiting—Cisplatin—urinary bladder cancer	4.29e-05	0.000931	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Epirubicin—urinary bladder cancer	4.27e-05	0.000928	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—urinary bladder cancer	4.27e-05	0.000926	CcSEcCtD
Ethinyl Estradiol—Rash—Cisplatin—urinary bladder cancer	4.25e-05	0.000924	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cisplatin—urinary bladder cancer	4.25e-05	0.000923	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Epirubicin—urinary bladder cancer	4.25e-05	0.000922	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Etoposide—urinary bladder cancer	4.23e-05	0.000918	CcSEcCtD
Ethinyl Estradiol—Nausea—Fluorouracil—urinary bladder cancer	4.23e-05	0.000918	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—urinary bladder cancer	4.22e-05	0.000916	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Methotrexate—urinary bladder cancer	4.21e-05	0.000914	CcSEcCtD
Ethinyl Estradiol—Back pain—Epirubicin—urinary bladder cancer	4.11e-05	0.000892	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—urinary bladder cancer	4.09e-05	0.000889	CcSEcCtD
Ethinyl Estradiol—Malaise—Methotrexate—urinary bladder cancer	4.09e-05	0.000888	CcSEcCtD
Ethinyl Estradiol—Dizziness—Etoposide—urinary bladder cancer	4.09e-05	0.000887	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—urinary bladder cancer	4.08e-05	0.000886	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—urinary bladder cancer	4.08e-05	0.000885	CcSEcCtD
Ethinyl Estradiol—Nausea—Cisplatin—urinary bladder cancer	4.01e-05	0.00087	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—urinary bladder cancer	3.99e-05	0.000866	CcSEcCtD
Ethinyl Estradiol—Cough—Methotrexate—urinary bladder cancer	3.96e-05	0.000859	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Doxorubicin—urinary bladder cancer	3.95e-05	0.000858	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—urinary bladder cancer	3.94e-05	0.000855	CcSEcCtD
Ethinyl Estradiol—Vomiting—Etoposide—urinary bladder cancer	3.93e-05	0.000853	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—urinary bladder cancer	3.93e-05	0.000853	CcSEcCtD
Ethinyl Estradiol—Rash—Etoposide—urinary bladder cancer	3.9e-05	0.000846	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Etoposide—urinary bladder cancer	3.89e-05	0.000845	CcSEcCtD
Ethinyl Estradiol—Headache—Etoposide—urinary bladder cancer	3.87e-05	0.000841	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	3.84e-05	0.000833	CcSEcCtD
Ethinyl Estradiol—Malaise—Epirubicin—urinary bladder cancer	3.83e-05	0.000831	CcSEcCtD
Ethinyl Estradiol—Discomfort—Methotrexate—urinary bladder cancer	3.82e-05	0.000828	CcSEcCtD
Ethinyl Estradiol—Back pain—Doxorubicin—urinary bladder cancer	3.8e-05	0.000825	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—urinary bladder cancer	3.78e-05	0.00082	CcSEcCtD
Ethinyl Estradiol—Cough—Epirubicin—urinary bladder cancer	3.7e-05	0.000804	CcSEcCtD
Ethinyl Estradiol—Infection—Methotrexate—urinary bladder cancer	3.68e-05	0.000799	CcSEcCtD
Ethinyl Estradiol—Nausea—Etoposide—urinary bladder cancer	3.67e-05	0.000797	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—urinary bladder cancer	3.64e-05	0.000791	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Methotrexate—urinary bladder cancer	3.63e-05	0.000788	CcSEcCtD
Ethinyl Estradiol—Anxiety—Epirubicin—urinary bladder cancer	3.6e-05	0.000782	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Methotrexate—urinary bladder cancer	3.6e-05	0.000781	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	3.59e-05	0.000779	CcSEcCtD
Ethinyl Estradiol—Discomfort—Epirubicin—urinary bladder cancer	3.57e-05	0.000775	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—urinary bladder cancer	3.54e-05	0.000769	CcSEcCtD
Ethinyl Estradiol—Oedema—Epirubicin—urinary bladder cancer	3.46e-05	0.000752	CcSEcCtD
Ethinyl Estradiol—Infection—Epirubicin—urinary bladder cancer	3.44e-05	0.000747	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—urinary bladder cancer	3.43e-05	0.000744	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—urinary bladder cancer	3.4e-05	0.000738	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Epirubicin—urinary bladder cancer	3.37e-05	0.000731	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—urinary bladder cancer	3.33e-05	0.000724	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	3.32e-05	0.000721	CcSEcCtD
Ethinyl Estradiol—Discomfort—Doxorubicin—urinary bladder cancer	3.3e-05	0.000717	CcSEcCtD
Ethinyl Estradiol—Oedema—Doxorubicin—urinary bladder cancer	3.21e-05	0.000696	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	3.2e-05	0.000694	CcSEcCtD
Ethinyl Estradiol—Fatigue—Methotrexate—urinary bladder cancer	3.19e-05	0.000693	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—urinary bladder cancer	3.18e-05	0.000691	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—urinary bladder cancer	3.14e-05	0.000683	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Doxorubicin—urinary bladder cancer	3.11e-05	0.000676	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Methotrexate—urinary bladder cancer	3.05e-05	0.000662	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Methotrexate—urinary bladder cancer	3.03e-05	0.000657	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	2.99e-05	0.000649	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—urinary bladder cancer	2.99e-05	0.000649	CcSEcCtD
Ethinyl Estradiol—Constipation—Epirubicin—urinary bladder cancer	2.96e-05	0.000643	CcSEcCtD
Ethinyl Estradiol—Urticaria—Methotrexate—urinary bladder cancer	2.94e-05	0.000639	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Methotrexate—urinary bladder cancer	2.93e-05	0.000635	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Methotrexate—urinary bladder cancer	2.93e-05	0.000635	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—urinary bladder cancer	2.85e-05	0.00062	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—urinary bladder cancer	2.83e-05	0.000615	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	2.77e-05	0.000601	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—urinary bladder cancer	2.76e-05	0.0006	CcSEcCtD
Ethinyl Estradiol—Urticaria—Epirubicin—urinary bladder cancer	2.75e-05	0.000598	CcSEcCtD
Ethinyl Estradiol—Constipation—Doxorubicin—urinary bladder cancer	2.74e-05	0.000595	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—urinary bladder cancer	2.74e-05	0.000595	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—urinary bladder cancer	2.74e-05	0.000595	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Methotrexate—urinary bladder cancer	2.73e-05	0.000592	CcSEcCtD
Ethinyl Estradiol—Asthenia—Methotrexate—urinary bladder cancer	2.66e-05	0.000577	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—urinary bladder cancer	2.64e-05	0.000574	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	2.62e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Pruritus—Methotrexate—urinary bladder cancer	2.62e-05	0.000569	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—urinary bladder cancer	2.55e-05	0.000554	CcSEcCtD
Ethinyl Estradiol—Urticaria—Doxorubicin—urinary bladder cancer	2.55e-05	0.000553	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—urinary bladder cancer	2.53e-05	0.00055	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—urinary bladder cancer	2.53e-05	0.00055	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Methotrexate—urinary bladder cancer	2.53e-05	0.00055	CcSEcCtD
Ethinyl Estradiol—Asthenia—Epirubicin—urinary bladder cancer	2.49e-05	0.00054	CcSEcCtD
Ethinyl Estradiol—Pruritus—Epirubicin—urinary bladder cancer	2.45e-05	0.000532	CcSEcCtD
Ethinyl Estradiol—Dizziness—Methotrexate—urinary bladder cancer	2.45e-05	0.000532	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Epirubicin—urinary bladder cancer	2.37e-05	0.000515	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—urinary bladder cancer	2.36e-05	0.000513	CcSEcCtD
Ethinyl Estradiol—Vomiting—Methotrexate—urinary bladder cancer	2.35e-05	0.000511	CcSEcCtD
Ethinyl Estradiol—Rash—Methotrexate—urinary bladder cancer	2.33e-05	0.000507	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Methotrexate—urinary bladder cancer	2.33e-05	0.000506	CcSEcCtD
Ethinyl Estradiol—Headache—Methotrexate—urinary bladder cancer	2.32e-05	0.000504	CcSEcCtD
Ethinyl Estradiol—Asthenia—Doxorubicin—urinary bladder cancer	2.3e-05	0.000499	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—urinary bladder cancer	2.29e-05	0.000497	CcSEcCtD
Ethinyl Estradiol—Pruritus—Doxorubicin—urinary bladder cancer	2.27e-05	0.000492	CcSEcCtD
Ethinyl Estradiol—Vomiting—Epirubicin—urinary bladder cancer	2.2e-05	0.000478	CcSEcCtD
Ethinyl Estradiol—Nausea—Methotrexate—urinary bladder cancer	2.2e-05	0.000477	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—urinary bladder cancer	2.19e-05	0.000476	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—urinary bladder cancer	2.18e-05	0.000474	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—urinary bladder cancer	2.18e-05	0.000474	CcSEcCtD
Ethinyl Estradiol—Headache—Epirubicin—urinary bladder cancer	2.17e-05	0.000471	CcSEcCtD
Ethinyl Estradiol—Dizziness—Doxorubicin—urinary bladder cancer	2.12e-05	0.00046	CcSEcCtD
Ethinyl Estradiol—Nausea—Epirubicin—urinary bladder cancer	2.06e-05	0.000447	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—urinary bladder cancer	2.04e-05	0.000443	CcSEcCtD
Ethinyl Estradiol—Rash—Doxorubicin—urinary bladder cancer	2.02e-05	0.000439	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—urinary bladder cancer	2.02e-05	0.000438	CcSEcCtD
Ethinyl Estradiol—Headache—Doxorubicin—urinary bladder cancer	2.01e-05	0.000436	CcSEcCtD
Ethinyl Estradiol—Nausea—Doxorubicin—urinary bladder cancer	1.9e-05	0.000413	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—TYMS—urinary bladder cancer	1.36e-05	0.000455	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	1.35e-05	0.000452	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—NCOR1—urinary bladder cancer	1.34e-05	0.00045	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—GSTM1—urinary bladder cancer	1.34e-05	0.00045	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—CREBBP—urinary bladder cancer	1.33e-05	0.000447	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	1.31e-05	0.000441	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	1.31e-05	0.000439	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—KRAS—urinary bladder cancer	1.31e-05	0.000439	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—KRAS—urinary bladder cancer	1.3e-05	0.000437	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ERCC2—urinary bladder cancer	1.29e-05	0.000434	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—UGT2B7—urinary bladder cancer	1.29e-05	0.000434	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—GPX1—urinary bladder cancer	1.28e-05	0.000431	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—ERCC2—urinary bladder cancer	1.28e-05	0.00043	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—HPGDS—urinary bladder cancer	1.28e-05	0.000429	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ENO2—urinary bladder cancer	1.28e-05	0.000429	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.27e-05	0.000427	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTZ1—urinary bladder cancer	1.26e-05	0.000424	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ERCC2—urinary bladder cancer	1.26e-05	0.000423	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GSTP1—urinary bladder cancer	1.26e-05	0.000421	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GSTT1—urinary bladder cancer	1.24e-05	0.000416	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.22e-05	0.00041	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MTHFR—urinary bladder cancer	1.22e-05	0.000408	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—TERT—urinary bladder cancer	1.21e-05	0.000407	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	1.2e-05	0.000404	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	1.2e-05	0.000402	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTO2—urinary bladder cancer	1.2e-05	0.000402	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NAT1—urinary bladder cancer	1.2e-05	0.000402	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	1.19e-05	0.0004	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HDAC4—urinary bladder cancer	1.19e-05	0.0004	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—MTHFR—urinary bladder cancer	1.19e-05	0.000398	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	1.18e-05	0.000395	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	1.17e-05	0.000394	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	1.17e-05	0.000393	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—TYMS—urinary bladder cancer	1.17e-05	0.000391	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CYP4B1—urinary bladder cancer	1.17e-05	0.000391	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—urinary bladder cancer	1.16e-05	0.00039	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MYC—urinary bladder cancer	1.16e-05	0.000388	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	0.000387	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	0.000387	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	1.15e-05	0.000385	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—FGFR3—urinary bladder cancer	1.11e-05	0.000374	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	1.11e-05	0.000372	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—HRAS—urinary bladder cancer	1.11e-05	0.000371	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GPX1—urinary bladder cancer	1.1e-05	0.000371	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	1.1e-05	0.000369	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SLC19A1—urinary bladder cancer	1.1e-05	0.000369	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—UGT2B7—urinary bladder cancer	1.1e-05	0.000368	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	1.09e-05	0.000367	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	1.09e-05	0.000366	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	0.000364	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	1.08e-05	0.000364	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PRSS3—urinary bladder cancer	1.07e-05	0.00036	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—ESR1—urinary bladder cancer	1.07e-05	0.000359	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	1.05e-05	0.000351	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NAT1—urinary bladder cancer	1.04e-05	0.00035	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTO2—urinary bladder cancer	1.04e-05	0.00035	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	1.03e-05	0.000346	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—NQO1—urinary bladder cancer	1.03e-05	0.000346	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—PPARG—urinary bladder cancer	1.02e-05	0.000343	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—SMC1A—urinary bladder cancer	1.02e-05	0.000342	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	0.000342	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	1.02e-05	0.000341	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	1e-05	0.000337	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1e-05	0.000336	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GLI1—urinary bladder cancer	1e-05	0.000335	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CYP4B1—urinary bladder cancer	9.87e-06	0.000331	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—CREBBP—urinary bladder cancer	9.82e-06	0.000329	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—PPARG—urinary bladder cancer	9.76e-06	0.000327	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	9.64e-06	0.000323	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PPARG—urinary bladder cancer	9.61e-06	0.000322	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	9.55e-06	0.00032	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CREBBP—urinary bladder cancer	9.48e-06	0.000318	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—CREBBP—urinary bladder cancer	9.38e-06	0.000315	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC19A1—urinary bladder cancer	9.32e-06	0.000313	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—CREBBP—urinary bladder cancer	9.23e-06	0.00031	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PRSS3—urinary bladder cancer	9.08e-06	0.000305	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—ESR2—urinary bladder cancer	8.9e-06	0.000298	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.87e-06	0.000298	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.83e-06	0.000296	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	8.76e-06	0.000294	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.73e-06	0.000293	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GSTP1—urinary bladder cancer	8.6e-06	0.000289	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	8.6e-06	0.000288	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—RHOA—urinary bladder cancer	8.58e-06	0.000288	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—TYMP—urinary bladder cancer	8.58e-06	0.000288	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	8.57e-06	0.000287	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.32e-06	0.000279	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PPARG—urinary bladder cancer	8.27e-06	0.000277	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	8.12e-06	0.000272	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—TYMS—urinary bladder cancer	8e-06	0.000268	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—CREBBP—urinary bladder cancer	7.94e-06	0.000266	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ERBB2—urinary bladder cancer	7.94e-06	0.000266	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PRSS3—urinary bladder cancer	7.91e-06	0.000265	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—urinary bladder cancer	7.91e-06	0.000265	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—NCOR1—urinary bladder cancer	7.91e-06	0.000265	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GSTM1—urinary bladder cancer	7.91e-06	0.000265	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTGS2—urinary bladder cancer	7.76e-06	0.00026	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NAT2—urinary bladder cancer	7.76e-06	0.00026	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	7.74e-06	0.00026	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GPX1—urinary bladder cancer	7.57e-06	0.000254	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTGS2—urinary bladder cancer	7.56e-06	0.000254	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	7.49e-06	0.000251	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	7.47e-06	0.000251	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ERCC2—urinary bladder cancer	7.43e-06	0.000249	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	7.28e-06	0.000244	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—TYMP—urinary bladder cancer	7.26e-06	0.000244	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	7.12e-06	0.000239	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—MTHFR—urinary bladder cancer	6.99e-06	0.000234	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	6.97e-06	0.000234	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	6.93e-06	0.000232	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—NCOR1—urinary bladder cancer	6.87e-06	0.00023	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—RBX1—urinary bladder cancer	6.85e-06	0.00023	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—CDKN1A—urinary bladder cancer	6.79e-06	0.000228	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	6.79e-06	0.000228	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTEN—urinary bladder cancer	6.77e-06	0.000227	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—RRM2—urinary bladder cancer	6.7e-06	0.000225	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PTEN—urinary bladder cancer	6.6e-06	0.000221	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NAT2—urinary bladder cancer	6.57e-06	0.00022	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTGS2—urinary bladder cancer	6.5e-06	0.000218	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EP300—urinary bladder cancer	6.46e-06	0.000217	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—ERCC2—urinary bladder cancer	6.46e-06	0.000217	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TSC1—urinary bladder cancer	6.44e-06	0.000216	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	6.43e-06	0.000216	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NAT1—urinary bladder cancer	6.43e-06	0.000216	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—TYMP—urinary bladder cancer	6.33e-06	0.000212	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—EP300—urinary bladder cancer	6.29e-06	0.000211	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—SRC—urinary bladder cancer	6.28e-06	0.000211	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	6.21e-06	0.000208	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ENO2—urinary bladder cancer	6.2e-06	0.000208	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HPGDS—urinary bladder cancer	6.2e-06	0.000208	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—JAG1—urinary bladder cancer	6.13e-06	0.000206	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	6.07e-06	0.000204	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTT1—urinary bladder cancer	6.01e-06	0.000202	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	5.88e-06	0.000197	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—urinary bladder cancer	5.83e-06	0.000195	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	5.78e-06	0.000194	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	5.74e-06	0.000192	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NAT2—urinary bladder cancer	5.72e-06	0.000192	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—PTEN—urinary bladder cancer	5.67e-06	0.00019	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—RRM2—urinary bladder cancer	5.67e-06	0.00019	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PPARG—urinary bladder cancer	5.67e-06	0.00019	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—urinary bladder cancer	5.63e-06	0.000189	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—urinary bladder cancer	5.56e-06	0.000187	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—EGFR—urinary bladder cancer	5.5e-06	0.000185	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—CREBBP—urinary bladder cancer	5.44e-06	0.000183	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—EP300—urinary bladder cancer	5.41e-06	0.000181	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	5.3e-06	0.000178	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HPGDS—urinary bladder cancer	5.25e-06	0.000176	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ENO2—urinary bladder cancer	5.25e-06	0.000176	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	5.22e-06	0.000175	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—KRAS—urinary bladder cancer	5.2e-06	0.000174	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	5.1e-06	0.000171	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	5.09e-06	0.000171	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	5.01e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	5e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NQO1—urinary bladder cancer	5e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—S100B—urinary bladder cancer	4.97e-06	0.000167	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—RRM2—urinary bladder cancer	4.94e-06	0.000166	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—PPARG—urinary bladder cancer	4.92e-06	0.000165	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	4.88e-06	0.000164	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—CREBBP—urinary bladder cancer	4.73e-06	0.000159	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HPGDS—urinary bladder cancer	4.57e-06	0.000153	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ENO2—urinary bladder cancer	4.57e-06	0.000153	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NCOR1—urinary bladder cancer	4.47e-06	0.00015	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTGS2—urinary bladder cancer	4.46e-06	0.000149	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTT1—urinary bladder cancer	4.44e-06	0.000149	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HRAS—urinary bladder cancer	4.42e-06	0.000148	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NQO1—urinary bladder cancer	4.23e-06	0.000142	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTP1—urinary bladder cancer	4.17e-06	0.00014	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.15e-06	0.000139	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	4.11e-06	0.000138	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TERT—urinary bladder cancer	3.94e-06	0.000132	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TYMP—urinary bladder cancer	3.9e-06	0.000131	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—PTEN—urinary bladder cancer	3.89e-06	0.00013	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—TYMS—urinary bladder cancer	3.88e-06	0.00013	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GSTM1—urinary bladder cancer	3.83e-06	0.000128	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NCOR1—urinary bladder cancer	3.83e-06	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—EP300—urinary bladder cancer	3.71e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NQO1—urinary bladder cancer	3.69e-06	0.000124	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GPX1—urinary bladder cancer	3.67e-06	0.000123	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—FGFR3—urinary bladder cancer	3.61e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ERCC2—urinary bladder cancer	3.6e-06	0.000121	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	3.58e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	3.53e-06	0.000118	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NAT2—urinary bladder cancer	3.52e-06	0.000118	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	3.41e-06	0.000115	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—MTHFR—urinary bladder cancer	3.39e-06	0.000114	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—TYMS—urinary bladder cancer	3.28e-06	0.00011	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	3.24e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	3.24e-06	0.000109	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GPX1—urinary bladder cancer	3.11e-06	0.000104	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTP1—urinary bladder cancer	3.07e-06	0.000103	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CREBBP—urinary bladder cancer	3.07e-06	0.000103	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	3.05e-06	0.000102	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—RRM2—urinary bladder cancer	3.04e-06	0.000102	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IGF1—urinary bladder cancer	3.04e-06	0.000102	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	2.87e-06	9.61e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—TYMS—urinary bladder cancer	2.86e-06	9.59e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NCOR1—urinary bladder cancer	2.83e-06	9.48e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GSTM1—urinary bladder cancer	2.83e-06	9.48e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.82e-06	9.45e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.82e-06	9.45e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—urinary bladder cancer	2.81e-06	9.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—RHOA—urinary bladder cancer	2.78e-06	9.33e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PPARG—urinary bladder cancer	2.75e-06	9.21e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.73e-06	9.17e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GPX1—urinary bladder cancer	2.71e-06	9.08e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ERCC2—urinary bladder cancer	2.66e-06	8.91e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—CREBBP—urinary bladder cancer	2.64e-06	8.85e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ERBB2—urinary bladder cancer	2.57e-06	8.64e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—MTHFR—urinary bladder cancer	2.5e-06	8.38e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CXCL8—urinary bladder cancer	2.44e-06	8.19e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—IL2—urinary bladder cancer	2.33e-06	7.83e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PPARG—urinary bladder cancer	2.32e-06	7.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CCND1—urinary bladder cancer	2.27e-06	7.63e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NQO1—urinary bladder cancer	2.27e-06	7.62e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	2.23e-06	7.49e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MMP9—urinary bladder cancer	2.21e-06	7.41e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CDKN1A—urinary bladder cancer	2.2e-06	7.38e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTEN—urinary bladder cancer	2.2e-06	7.36e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTGS2—urinary bladder cancer	2.16e-06	7.24e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EP300—urinary bladder cancer	2.09e-06	7.02e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—SRC—urinary bladder cancer	2.04e-06	6.83e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PPARG—urinary bladder cancer	2.02e-06	6.79e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—CREBBP—urinary bladder cancer	1.95e-06	6.52e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.89e-06	6.35e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—PTEN—urinary bladder cancer	1.88e-06	6.32e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	1.83e-06	6.13e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—urinary bladder cancer	1.82e-06	6.12e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—EP300—urinary bladder cancer	1.8e-06	6.02e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—EGFR—urinary bladder cancer	1.78e-06	5.99e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.76e-06	5.91e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.74e-06	5.84e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.74e-06	5.84e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KRAS—urinary bladder cancer	1.69e-06	5.65e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.67e-06	5.59e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.64e-06	5.49e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—PTEN—urinary bladder cancer	1.59e-06	5.35e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTGS2—urinary bladder cancer	1.59e-06	5.34e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.54e-06	5.16e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—EP300—urinary bladder cancer	1.52e-06	5.1e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—urinary bladder cancer	1.5e-06	5.03e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HRAS—urinary bladder cancer	1.43e-06	4.81e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—PTEN—urinary bladder cancer	1.39e-06	4.66e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—EP300—urinary bladder cancer	1.32e-06	4.44e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPARG—urinary bladder cancer	1.25e-06	4.18e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	1.2e-06	4.02e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	9.81e-07	3.29e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PTEN—urinary bladder cancer	8.56e-07	2.87e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—EP300—urinary bladder cancer	8.16e-07	2.74e-05	CbGpPWpGaD
